Phase III Study of Intravenous Tramadol for the Management of Post-Operative Pain in Patients Undergoing Bunionectomy Surgery

Trial Profile

Phase III Study of Intravenous Tramadol for the Management of Post-Operative Pain in Patients Undergoing Bunionectomy Surgery

Planning
Phase of Trial: Phase III

Latest Information Update: 09 Aug 2017

At a glance

  • Drugs Tramadol (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Aug 2017 According to a Fortress Biotech media release, Avenue Therapeutics (subsidiary of Fortress Biotech) is on track to initiate this trial in the third quarter of 2017.
    • 09 Aug 2017 Planned initiation date changed from 31 Jan 2017 to 1 Sep 2017, according to a Fortress Biotech media release.
    • 16 Mar 2017 According to a Fortress Biotech media release, this is one of three phase III trials of IV tramadol for the management of post-operative pain.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top